ArticleAmerican journal of ophthalmology case reports2026
Pediatric orbital IgG4-related disease: A case series.
Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Immunoglobulin G4 (IgG4)-related orbital disease is an uncommon fibroinflammatory condition characterized by IgG4-positive plasma cell infiltration of orbital structures. While its features are well-recognized in adults, pediatric cases remain exceedingly rare, with limited reports in the literature. Observations: We describe three pediatric female patients with IgG4-related orbital disease, aged 5, 11, and 16 years, who presented with progressive proptosis and globe displacement. Orbital imaging in all cases demonstrated infiltrative lesions involving the lacrimal gland. Histopathologic confirmation was obtained in each, showing dense lymphoplasmacytic infiltrates with cluster of differentiation 138 (CD138) positivity and a high proportion of IgG4-positive plasma cells. Treatment primarily consisted of systemic corticosteroids and immunomodulatory therapy. Rituximab was successfully administered in one refractory case, leading to substantial clinical improvement. Conclusions and importance: Pediatric IgG4-related orbital disease, although rare, should be considered in the differential diagnosis of orbital masses in children, particularly when the lacrimal gland is involved. Histopathology remains essential for diagnosis, and systemic corticosteroids constitute the mainstay of therapy, with immunosuppressants and biologics reserved for refractory disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.